Search Results - "Doorduijn, Jeanette K"
-
1
Is there a future for maintenance temozolomide chemotherapy in PCNSL?
Published in Neuro-oncology (Charlottesville, Va.) (06-04-2023)Get full text
Journal Article -
2
-
3
Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo-Controlled Trial
Published in Clinical infectious diseases (01-05-2008)“…Background. Invasive pulmonary aspergillosis (IPA) is a significant problem in patients with chemotherapy-induced prolonged neutropenia. Because pulmonary…”
Get full text
Journal Article -
4
Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis
Published in Hematological oncology (01-12-2019)“…The CD‐20 antibody rituximab is a standard component of treatment of non‐Hodgkin B‐cell lymphomas, including diffuse large B‐cell lymphoma (DLBCL). Primary…”
Get full text
Journal Article -
5
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019
Published in Blood cancer journal (New York) (13-01-2023)“…The longevity of patients with chronic lymphocytic leukemia (CLL) has improved progressively over the past decades, making it essential to understand long-term…”
Get full text
Journal Article -
6
High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial
Published in Journal of clinical oncology (01-11-2003)“…To determine, in a randomized clinical trial, whether high-dose therapy (HDT) followed by autologous stem-cell transplantation is more effective than standard…”
Get full text
Journal Article -
7
Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial
Published in PloS one (26-05-2010)“…Catheter-related bloodstream infection (CRBSI) results in significant attributable morbidity and mortality. In this randomized, double-blind,…”
Get full text
Journal Article -
8
Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma
Published in Leukemia & lymphoma (02-09-2017)“…Central nervous system (CNS) involvement in systemic B-cell non-Hodgkin lymphoma (B-NHL) at diagnosis (sysCNS) is rare. We investigated the outcome of 21…”
Get full text
Journal Article -
9
-
10
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Published in Haematologica (Roma) (01-01-2019)“…Lenalidomide has been proven to be effective but with a distinct and difficult to manage toxicity profile in the context of chronic lymphocytic leukemia,…”
Get full text
Journal Article -
11
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation – an International Primary Central Nervous System Lymphoma Study Group project
Published in Haematologica (Roma) (01-05-2013)“…Autologous stem cell transplantation has greatly improved the prognosis of systemic recurrent non-Hodgkin's lymphoma. However, no prospective data are…”
Get full text
Journal Article -
12
Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia–Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study
Published in Clinical infectious diseases (15-12-2008)“…Background. Invasive aspergillosis (IA) is a leading cause of mortality in patients with acute leukemia. Management of IA is expensive, which makes prevention…”
Get full text
Journal Article -
13
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up
Published in HemaSphere (01-06-2024)“…Highlights This EHA‐ESMO Clinical Practice Guideline provides key recommendations for managing primary DLBCL of the CNS. The guideline covers clinical, imaging…”
Get full text
Journal Article -
14
Flow cytometry shows added value in diagnosing lymphoma in brain biopsies
Published in Cytometry. Part B, Clinical cytometry (01-11-2018)“…Background To assess the sensitivity, specificity and turnaround time of flow cytometric analysis on brain biopsies compared to histology plus…”
Get full text
Journal Article -
15
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the Netherlands
Published in EJHaem (01-02-2022)“…Studies on conditional relative survival (CRS) in chronic lymphocytic leukaemia (CLL) have hitherto been lacking in the literature. We predicted up‐to‐date…”
Get full text
Journal Article -
16
HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma
Published in HemaSphere (01-02-2020)“…Supplemental Digital Content is available in the text…”
Get full text
Journal Article -
17
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Published in The lancet oncology (01-02-2019)“…The prognosis for primary CNS lymphoma has improved with the use of high-dose methotrexate-based chemotherapy, but patient outcomes remain poor. Rituximab, a…”
Get full text
Journal Article -
18
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
Published in Journal of clinical oncology (20-01-2020)“…In an update of the randomized, open-label, phase III European Mantle Cell Lymphoma (MCL) Elderly trial (ClinicalTrials.gov identifier: NCT00209209), published…”
Get full text
Journal Article -
19
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Published in Leukemia (01-11-2019)Get full text
Journal Article -
20
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Published in Leukemia (01-01-2021)“…PTCL patients exhibit poor survival with existing treatments. We investigated the efficacy of CHOP combined with alemtuzumab in 116 PTCL patients age 61–80 in…”
Get full text
Journal Article